0000000000190541

AUTHOR

Lea Ellwardt

0000-0001-9292-2392

showing 2 related works from this author

Conflict and segregation in networks: An experiment on the interplay between individual preferences and social influence

2016

We examine the interplay between a person's individual preference and the social influence others exert. We provide a model of network relationships with conflicting preferences, where individuals are better off coordinating with those around them, but where not all have a preference for the same action. We test our model in an experiment, varying the level of conflicting preferences between individuals. Our findings suggest that preferences are more salient than social influence, under conflicting preferences: subjects relate mainly with others who have the same preferences. This leads to two undesirable outcomes: network segregation and social inefficiency. The same force that helps peopl…

Statistics and Probability0209 industrial biotechnology021103 operations researchApplied Mathematicsjel:D85jel:C72jel:D820211 other engineering and technologiesjel:C6202 engineering and technologyEconomiaHeterogeneity Social Networks Formation Equilibrium selectionPreferenceTest (assessment)020901 industrial engineering & automationAction (philosophy)SalientEquilibrium selectionModeling and SimulationEconomicsInefficiencySocial psychologySocial influenceJournal of Dynamics and Games
researchProduct

Monitoring B-cell repopulation after depletion therapy in neurologic patients.

2017

ObjectiveTo determine the factors that influence B-cell repopulation after B-cell depletion therapy in neurologic patients and derive recommendations for monitoring and dosing of patients.MethodsIn this study, we determined the association of body surface area (BSA; calculated by body weight and height with the Dubois formula), sex, pretreatment therapy, age, CSF data, and white blood cell counts with the risk and timing of B-cell repopulation, defined as 1% CD19+ cells (of total lymphocytes), following 87 B cell–depleting anti-CD20 treatment cycles of 45 neurologic patients (28 women; mean age ± SD, 44.5 ± 15.0 years).ResultsPatients with a larger BSA had a higher probability to reach 1% C…

0301 basic medicine40medicine.medical_specialty41132LymphocyteUrologyCD19Article03 medical and health sciences0302 clinical medicineWhite blood cellMedicineDosingAdverse effectB cellBody surface areabiologybusiness.industry14323030104 developmental biologymedicine.anatomical_structureNeurologybiology.proteinRepopulationNeurology (clinical)business030217 neurology & neurosurgeryNeurology(R) neuroimmunologyneuroinflammation
researchProduct